These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 1499106)
21. Orally administered heparins prevent arterial thrombosis in a rat model. Pinel C; Wice SM; Hiebert LM Thromb Haemost; 2004 May; 91(5):919-26. PubMed ID: 15116252 [TBL] [Abstract][Full Text] [Related]
22. Intimatan prevents arterial and venous thrombosis in a canine model of deep vessel wall injury. Hennan JK; Hong TT; Shergill AK; Driscoll EM; Cardin AD; Lucchesi BR J Pharmacol Exp Ther; 2002 Jun; 301(3):1151-6. PubMed ID: 12023550 [TBL] [Abstract][Full Text] [Related]
23. Active site-inactivated factor VIIa prevents thrombosis without increased surgical bleeding: topical and intravenous administration in a rat model of deep arterial injury. Söderström T; Hedner U; Arnljots B J Vasc Surg; 2001 May; 33(5):1072-9. PubMed ID: 11331851 [TBL] [Abstract][Full Text] [Related]
24. Thrombogenicity of vascular cells. Comparison between endothelial cells isolated from different sources and smooth muscle cells and fibroblasts. Zwaginga JJ; de Boer HC; IJsseldijk MJ; Kerkhof A; Muller-Berghaus G; Gruhlichhenn J; Sixma JJ; de Groot PG Arteriosclerosis; 1990; 10(3):437-48. PubMed ID: 2344300 [TBL] [Abstract][Full Text] [Related]
25. Prevention of laser arterial thrombus formation with unfractionated heparin. Doutremepuich F; Aguejouf O; Azougagh Oualane F; Doutremepuich C Haemostasis; 1993; 23(5):244-8. PubMed ID: 8175044 [TBL] [Abstract][Full Text] [Related]
26. Antithrombotic effects of orally active synthetic antagonist of activated factor X in nonhuman primates. Yokoyama T; Kelly AB; Marzec UM; Hanson SR; Kunitada S; Harker LA Circulation; 1995 Aug; 92(3):485-91. PubMed ID: 7634464 [TBL] [Abstract][Full Text] [Related]
27. Cross-modulatory effects of clopidogrel and heparin on platelet and fibrin incorporation in thrombosis. Cooley BC; Herrera AJ Blood Coagul Fibrinolysis; 2013 Sep; 24(6):593-8. PubMed ID: 23492917 [TBL] [Abstract][Full Text] [Related]
29. Thrombogenicity of heparin and non-heparin bound arterial prostheses: an in vitro evaluation. Mohamed MS; Mukherjee M; Kakkar VV J R Coll Surg Edinb; 1998 Jun; 43(3):155-7. PubMed ID: 9654873 [TBL] [Abstract][Full Text] [Related]
30. Entry and distribution of fluorescent antiproliferative heparin derivatives into rat vascular smooth muscle cells: comparison between heparin-sensitive and heparin-resistant cultures. Bârzu T; Pascal M; Maman M; Roque C; Lafont F; Rousselet A J Cell Physiol; 1996 Apr; 167(1):8-21. PubMed ID: 8698843 [TBL] [Abstract][Full Text] [Related]
31. Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets. Mailhac A; Badimon JJ; Fallon JT; Fernández-Ortiz A; Meyer B; Chesebro JH; Fuster V; Badimon L Circulation; 1994 Aug; 90(2):988-96. PubMed ID: 8044972 [TBL] [Abstract][Full Text] [Related]
32. [Antiatherogenic action of heparin]. Stajszczyk M; Gmiński J Postepy Hig Med Dosw; 1994; 48(3):275-90. PubMed ID: 7971602 [TBL] [Abstract][Full Text] [Related]